Religare Enterprises Reports FY26 Profit of ₹73 Crore Amid Revenue Growth

Consolidated Net Profit for FY26 stood at ₹73.16 crore, while Total Revenue reached ₹8,493.84 crore.

Consolidated quarterly profit in Q4 FY26 was ₹95.65 crore on revenue of ₹2,473.30 crore.

Financial Results and Key Developments

Religare Enterprises Ltd (REL) has announced its financial results for the fiscal year and quarter ending March 31, 2026.

The company reported a consolidated net profit of ₹73.16 crore for FY26, a significant turnaround from previous periods, on total revenue of ₹8,493.84 crore.

Consolidated revenue showed robust year-on-year growth, up 14.70% from ₹7,405.47 crore in FY25.

Quarterly performance for Q4 FY26 was even stronger, with a net profit of ₹95.65 crore and revenue at ₹2,473.30 crore, marking a 20.66% year-on-year increase in revenue.

On a standalone basis, however, the company reported a net loss of ₹33.80 crore for FY26, with total income at ₹16.44 crore. The standalone Q4 FY26 also registered a loss of ₹12.36 crore.

Investor Significance

The key highlight for investors is the withdrawal of the RBI's Corrective Action Plan (CAP) for its subsidiary, Religare Finvest Ltd (RFL), effective July 23, 2025.

This signifies a major regulatory hurdle cleared, allowing RFL greater operational freedom.

Consolidated financial performance shows growth in scale and profitability, contributing positively to the group's overall financial health.

However, the persistent losses in the standalone entity and the ongoing dividend prohibition by the RBI continue to present challenges and limit direct shareholder returns.

Background: CAP and Dividend Restrictions

Religare Finvest Ltd (RFL) was placed under the RBI's Corrective Action Plan (CAP) in January 2021.

This stringent measure was due to concerns over RFL's capital adequacy, asset quality, and past governance lapses, which stemmed from issues within the broader Religare group.

The withdrawal of this CAP by the RBI marks a crucial milestone, suggesting that RFL has successfully implemented remedial actions and met the central bank's requirements for stability and compliance.

Religare Enterprises has been under an RBI directive since 2019, prohibiting it from declaring any dividends to shareholders.

This restriction is a legacy of past financial and governance missteps within the group.

The company's subsidiary, Care Health Insurance Limited (CHIL), has also faced regulatory actions, including a ₹1 crore penalty imposed by the IRDAI for non-adherence to certain operational norms.

Furthermore, the company is navigating an income tax dispute, with the demand currently reduced to ₹108.53 crore, indicating an ongoing legal and financial overhang.

Operational and Shareholder Outlook

Religare Finvest Ltd (RFL) gains operational flexibility and can pursue growth initiatives without RBI CAP constraints.

The group's overall financial health is expected to improve with RFL's rehabilitation.

Shareholders will continue to face restrictions on dividend payouts due to the existing RBI directive.

The standalone entity's performance remains a concern, requiring strategic attention.

Attention will be needed regarding the ongoing income tax litigation and subsidiary regulatory issues.

Key Risks and Concerns

The enduring prohibition on declaring dividends to shareholders by the RBI remains a significant factor limiting returns.

Ongoing litigation concerning the income tax demand of ₹108.53 crore poses a potential financial burden.

The ₹1 crore penalty on subsidiary Care Health Insurance Limited (CHIL) by the IRDAI highlights compliance challenges.

The persistent net losses reported by the standalone entity indicate structural issues that need resolution.

Industry Benchmarks

Bajaj Finance, a leading NBFC, reported stronger standalone profitability and higher revenue growth rates, benefiting from its focus on consumer finance and robust risk management.

Shriram Finance, another major player, has shown strong AUM growth post-merger and maintains a robust profit profile in vehicle and MSME lending.

Cholamandalam Investment and Finance Company has consistently demonstrated steady asset growth and profitability in its diversified financial services portfolio, including vehicle and home loans.

Looking Ahead

The actual performance and strategic initiatives undertaken by Religare Finvest Ltd (RFL) post-RBI CAP withdrawal.

Any progress or resolution in the ongoing income tax litigation.

Management's plans and timeline for improving the standalone entity's financial performance.

Potential timelines for the lifting of the RBI's dividend prohibition, if any positive developments emerge.

Operational updates and growth trajectory of the subsidiary, Care Health Insurance Limited (CHIL).